Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
I-Chia LiuAdam L HoltzmanRonny L RotondoDaniel J IndelicatoSridharan GururanganRobert CavaliereBridgette CarterChristopher G MorrisDaryoush TavanaiepourMichael S RutenbergPublished in: Journal of neuro-oncology (2021)
Proton CSI in adult medulloblastoma patients is very well tolerated and shows promising disease control and survival outcomes. These data support the standard use of proton CSI for adult medulloblastoma.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- prognostic factors
- childhood cancer
- oxidative stress
- electronic health record
- peritoneal dialysis
- type diabetes
- respiratory failure
- metabolic syndrome
- patient reported outcomes
- insulin resistance
- artificial intelligence
- glycemic control
- weight loss
- oxide nanoparticles